Charles Russell Speechlys advises Copyright Clearance Center on the acquisition of IXXUS
Charles Russell Speechlys has advised Copyright Clearance Center (CCC), a firm dedicated to creating global licensing and content solutions, on its acquisition of Ixxus, a software professional services firm and leading provider of publishing solutions.
CCC will explore opportunities to extend the value of licensing through the new service offerings Ixxus provides, and continue expanding its presence in the publishing market through ongoing product development and sales of its RightsLink permissions and author services SaaS products. The company will also continue to offer SaaS-based content workflow, text and data mining and document delivery solutions for the corporate sector through its RightFind content solution suite.
“The team at Charles Russell Speechlys provided exceptional direction and skilled guidance throughout the acquisition process,” said Dan Kopko, Deputy General Counsel, CCC. “They helped deliver a deal that brings combined capabilities and solutions from two of the industry’s leading intermediaries to publishers and their enterprise customers. ”
Commenting on the transaction, Malcolm MacDougall, Corporate Partner, said “It was a pleasure working with the CCC team on this deal and we are delighted to have assisted in bringing the transaction to a successful conclusion. We look forward to supporting CCC as the firm continues to expand its presence in the publishing market”.
The Charles Russell Speechlys core team comprised, Corporate Associate Amy Utley, Corporate Trainee Freddie Spearman, Corporate Tax Associate Helen Coward, IT/IP Partner Mark Bailey and Senior Associate George Willis, as well as Employment Senior Associate Emilie Bennetts.
News & Insights
Chares Russell Speechlys advises Turner Parkinson on its sale to Knights
Charles Russell Speechlys has advised independent business law firm Turner Parkinson LLP on its acquisition by Knights 1759.
Charles Russell Speechlys advises Kreos and SVB on £20m growth capital investment to Mereo BioPharma
We advised Kreos Capital and Silicon Valley Bank on the refinancing of £20 million growth capital investment to Mereo BioPharma Group
ECM and Brexit: business as usual?
We consider how ECM could be affected by the UK's impending departure from the EU